Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707): Gewinn- und Verlustrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 7,43 Renminbi Yuan | 11,19 Renminbi Yuan | 6,72 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 10,41 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 1.615.651.020 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 3.990.678,037 | 3.923.585,842 | 3.931.387,278 | 3.712.720,454 | 3.686.692,951 | 2.914.880,93 | 2.469.669,304 | 1.700.330,666 | 1.112.726,003 | 581.913,037 | 468.728 | 416.121,1 | 499.817,3 |
Herstellungskosten | 2.418.108,674 | 2.112.082,093 | 3.272.249,149 | 1.778.215,19 | 1.603.348,982 | 1.235.877,438 | 1.204.330,185 | 859.962,218 | 596.684,399 | 337.007,264 | 340.087,9 | 326.229,1 | 367.892 |
Bruttoergebnis | 1.572.569,363 | 1.811.503,749 | 659.138,129 | 1.934.505,264 | 2.083.343,969 | 1.679.003,492 | 1.265.339,119 | 840.368,448 | 516.041,604 | 244.905,773 | 128.640,099 | 89.892 | 131.925,3 |
▸ Brutto-Marge | 39,41% | 46,17% | 16,77% | 52,1% | 56,51% | 57,6% | 51,24% | 49,42% | 46,38% | 42,09% | 27,44% | 21,6% | 26,39% |
Betriebliche Aufwendungen | 991.202,317 | 817.175,428 | 953.846,999 | 760.953,329 | 901.410,68 | 802.021,314 | 597.697,799 | 379.937,215 | 163.599,609 | 83.830,26 | 30.045,899 | 30.616,3 | 52.183,4 |
Operativer Gewinn/Verlust | 581.367,045 | 994.328,321 | -294.708,87 | 1.173.551,935 | 1.181.933,289 | 876.982,178 | 667.641,32 | 460.431,233 | 352.441,995 | 161.075,513 | 98.594,2 | 59.275,7 | 79.741,9 |
▸ Operative Marge | 14,57% | 25,34% | -7,5% | 31,61% | 32,06% | 30,09% | 27,03% | 27,08% | 31,67% | 27,68% | 21,03% | 14,24% | 15,95% |
Zinsen (Netto) | -36.603,093 | -58.841,638 | -53.061,66 | -26.274,479 | -82.102,678 | -59.236,92 | -19.823,157 | -3.048,537 | -4.078,255 | -1.693,014 | -5.334,6 | -4.594,2 | -7.188,8 |
▸ Zinsausgaben | 55.249,524 | 78.036,12 | 81.045,087 | 59.667,604 | 94.144,495 | 60.720,359 | 23.259,305 | 9.584,947 | 4.781,642 | 1.877,3 | 5.334,6 | 4.594,2 | 7.188,8 |
▸ Zinseinnahmen | 18.646,431 | 19.194,482 | 27.983,427 | 33.393,125 | 12.041,817 | 1.483,439 | 3.436,148 | 6.536,41 | 703,387 | 184,286 | - | - | - |
Andere Ausgaben | -154.652,414 | -56.547,067 | -53.012,024 | -38.091,808 | -103.923,137 | -96.886,597 | -32.547,472 | -10.336,323 | -7.840,583 | -114.224,434 | -8.262,2 | -6.325,4 | -8.819,2 |
Gewinn vor Steuern | 699.416,367 | 992.033,75 | -294.758,506 | 1.185.369,264 | 1.203.753,748 | 914.631,855 | 680.365,635 | 467.719,019 | 356.204,323 | 273.606,933 | 101.521,8 | 61.006,9 | 81.372,3 |
Steueraufwand | - | 165.934,741 | -105.311,956 | 98.850,189 | 139.837,918 | 117.977,16 | 74.123,76 | 43.169,881 | 41.981,918 | 16.367,337 | 13.968,3 | 10.547,4 | 11.058,8 |
Minderheitenanteil | 117.880,213 | -45,866 | -0,761 | -4.314,132 | 4.622,496 | -9.467,491 | 1.280,269 | - | - | - | - | -30,5 | -2,7 |
Nettogewinn/-verlust | 581.536,154 | 826.144,875 | -189.445,789 | 1.090.833,207 | 1.059.293,334 | 806.122,186 | 604.961,606 | 424.549,138 | 314.222,405 | 257.239,596 | 87.553,5 | 50.490 | 70.316,2 |
▸ Netto-Marge | 14,57% | 21,06% | -4,82% | 29,38% | 28,73% | 27,66% | 24,5% | 24,97% | 28,24% | 44,21% | 18,68% | 12,13% | 14,07% |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.